Biometric Data and Privacy

As the Covid-19 pandemic has swept across the world, organisations have increasingly looked to new, contactless technology. Biometric data is a powerful tool for identification which enables much of our modern contactless technology. This technology is underpinning the careful balancing act that is sustainably managing the ongoing health risks posed by COVID-19, and the reopening …
>> Read more

Katie v Katy: A rose by any other name

Trade mark owners can invest considerable effort in promoting and establishing the reputation of their brand, and so are justifiably angered if someone else comes along and starts using the same mark. Normally, registering your trade mark means that you would have remedies against an infringing third party – but what happens when your brand …
>> Read more

POF welcomes new attorney, Paul Goodall

Phillips Ormonde Fitzpatrick extends a warm welcome to our newest patent attorney, Paul Goodall, who has recently joined our Sydney office as a member of our Electronics, Physics and IT team. Paul has seven years experience working in the engineering field. During his career, he has predominately focussed on electronics and telecommunications engineering, working on …
>> Read more

IP Australia extends COVID-19 extensions of time to 30 November 2020

As noted in our previous blog post, IP Australia introduced a new streamlined process for extension of time requests for Applicants impacted by COVID-19.  These arrangements have now been extended until at least 30 November 2020. IP Australia are also allowing a further streamlined COVID-19 extension even if you have previously received an extension.   By way of reminder, extension of time is available …
>> Read more

Australian High Court refuses to hear Rokt software patent appeal

The High Court of Australia has dismissed an application for special leave to appeal from the Commissioner of Patents v Rokt Pte Ltd 1 of the Full Court of the Federal Court of Australia. As we have previously indicated, the law relating to the patentability of computer-implemented inventions is beginning to look settled in Australia by the decisions in Encompass …
>> Read more

2020 Knowledge Commercialisation Australasia award winners

Congratulations to CSIRO for winning the KCA Best Research Commercialisation Award at today’s KCA digital awards ceremony. CSIRO’s submission was based on being able to quickly and accurately X-ray ore to see how much gold is inside. The system, PhotonAssay, uses high-energy X-rays to increase gold recovery by 1-3%, which is worth $2 billion a …
>> Read more

POF recognised as a leading Trade Mark Prosecution firm

We are very pleased to announce that we’ve been recognised as a leading Trade Mark Prosecution firm by Asia IP in their 2020 Trade Mark Survey. This achievement is a great reflection of the dedication and hard work of our Trade Mark attorneys. Asia IP determines their rankings via thousands of corporate counsels worldwide, who …
>> Read more

Ferrari takes its 488 Pista Spider design to a hearing and prevails

The Australian Designs Office has recently issued its decision[1] concerning an adverse examination report for a Car and Toy Car design registration owned by Ferrari. The Design relates to the 488 Pista Spider, Ferrari’s best ever open-top performance vehicle. Pleasingly for Ferrari the Australian Designs Office granted a certificate of examination on 14 July 2020. …
>> Read more

COVID-19: Put staff at the centre of your decision making

The first time we really paid attention to COVID-19 was in early February this year. By mid-March, we had set-up a COVID-19 Response Team including our heads of IT and People & Development, reviewed our readiness to have everyone working from home, run a successful IT stress test with 40% of our people working from …
>> Read more

No compensation for the Commonwealth: Australia v Sanofi

In the keenly awaited decision in Commonwealth of Australia v Sanofi1, the Federal Court has dismissed the Commonwealth’s $325 million claim for compensation made against Sanofi arising from a patent infringement suit brought against Apotex Australia (Apotex), the Australian subsidiary of the Canadian generic drug company Apotex Canada. Read more here >>